Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast Cancer

NCT00077363 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

NIH

Sponsor class

Conditions

Recurrent Breast Cancer
Stage IV Breast Cancer

Interventions

DRUG: tipifarnib
DRUG: capecitabine

Sponsor

National Cancer Institute (NCI)